The drug-pricing bill wading through Congress: 3 things to know

For months, legislators have chipped away at President Joe Biden’s Build Back Better Act, with the resulting leftovers centering around lowering drug costs for Medicare and Medicaid beneficiaries, according to The Washington Post.

Advertisement

Two more things to know:

1. The Senate version of the bill’s biggest targets are to require drugmakers to pay Medicare if the drug’s price rises faster than inflation rates, which would begin in 2023, and to allow the HHS to negotiate prices for drugs, which would take effect in 2026.

2. Another tenet of the legislation is limiting the copay for Medicare and Medicaid recipients, which is expected to pass into law, according to CNN.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.